Technology
The NIH's recent proposal to limit the number of grants per researcher has sparked varied responses, highlighting ongoing concerns in the biomedical research arena.
September 01, 2026
Finance
MAHA's efforts to reshape American nutrition encounter hurdles stemming from a declining dietitian workforce.
September 01, 2026
Finance
Updated guidelines from leading headache organizations emphasize new migraine treatments while addressing gaps in patient awareness and access.
August 31, 2026
Technology
Novartis' latest drug, pacibekitug, successfully reduces inflammation in a Phase 2 study, suggesting potential for cardiovascular treatment.
August 29, 2026
Technology
The Lindsay Clancy case highlights systemic flaws in maternal mental health care, raising concerns about its impact on psychiatrist willingness to treat patients.
August 28, 2026
Technology
AstraZeneca and Ionis' heart disease treatment faced an unexpected failure, raising concerns and interest among biotech competitors like Alnylam.
August 28, 2026
Sports
Members of a federal autism advisory committee controversially endorse vaccines as a cause of autism, despite overwhelming scientific refutation.
August 28, 2026
Technology
AstraZeneca's heart disease trial disappoints, showing no added benefit, while a court affirms FDA's handling of drug shortages for prominent diabetes treatments.
August 28, 2026
Technology
Cytokinetics is set to submit aficamten for FDA approval, potentially the first drug approved for non-obstructive hypertrophic cardiomyopathy.
August 28, 2026
Technology
AstraZeneca's recent heart disease trial failure underscores the effectiveness of stabilizers over silencers for treating ATTR-CM.
August 28, 2026
Finance
The federal autism advisory committee discusses vaccines as potential autism triggers, sparking controversy amidst calls for more research and transparency.
August 28, 2026
Technology
A year after resigning from the CDC, former staff members highlight ongoing issues and advocate for a reformed public health system free from political bias.
August 28, 2026
Technology
Roivant's new therapy, Lisraya, recently approved by the FDA, offers a non-steroidal option for treating dermatomyositis.
August 27, 2026
Technology
Health Secretary Robert F. Kennedy Jr. faces backlash over vaccine misinformation as PA confirms measles-related deaths; tensions escalate with state officials.
August 26, 2026
Finance
Recent studies highlight how coronary artery calcium scans can inform statin treatment decisions, especially in borderline risk cases.
August 26, 2026